Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Up front

Up front Diabetologia (2017) 60:1559–1560 DOI 10.1007/s00125-017-4382-4 Competition for publication in Diabetologia continues to grow, and less than 20% of papers are accepted. Of all the high-quality papers that appear in this month’s issue I want to draw your attention to the articles that I think are particularly interesting. The articles are summarised here. Our publisher, Springer, has kindly made the full text of each of these papers freely available. I hope you enjoy reading them! Sally M. Marshall, Editor 60 years of metformin use: a glance at the past and a metformin on cancer incidence and mortality, is covered look to the future by Heckman-Stoddard et al (DOI 10.1007/s00125-017- 4372-6). Finally, to address the heterogeneity in response To mark the 60th anniversary of the first clinical use of met- to metformin therapy, Jose Florez (DOI 10.1007/s00125- formin for diabetes, Diabetologia has commissioned a series 017-4335-y) advises how a personalised approach may be of articles on the many evolving (and controversial) aspects achieved using genetic studies. In summary, this review of metformin use. To begin, a historical overview is provided series demonstrates how metformin shows promise in many conditions, but how long can this drug remain at by Clifford Bailey (DOI http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetologia Springer Journals

Up front

Diabetologia , Volume 60 (9) – Aug 3, 2017
Download PDF
2 pages

Loading next page...
 
/lp/springer_journal/up-front-nXMW0sdwej

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Medicine & Public Health; Internal Medicine; Metabolic Diseases; Human Physiology
ISSN
0012-186X
eISSN
1432-0428
DOI
10.1007/s00125-017-4382-4
Publisher site
See Article on Publisher Site

Abstract

Diabetologia (2017) 60:1559–1560 DOI 10.1007/s00125-017-4382-4 Competition for publication in Diabetologia continues to grow, and less than 20% of papers are accepted. Of all the high-quality papers that appear in this month’s issue I want to draw your attention to the articles that I think are particularly interesting. The articles are summarised here. Our publisher, Springer, has kindly made the full text of each of these papers freely available. I hope you enjoy reading them! Sally M. Marshall, Editor 60 years of metformin use: a glance at the past and a metformin on cancer incidence and mortality, is covered look to the future by Heckman-Stoddard et al (DOI 10.1007/s00125-017- 4372-6). Finally, to address the heterogeneity in response To mark the 60th anniversary of the first clinical use of met- to metformin therapy, Jose Florez (DOI 10.1007/s00125- formin for diabetes, Diabetologia has commissioned a series 017-4335-y) advises how a personalised approach may be of articles on the many evolving (and controversial) aspects achieved using genetic studies. In summary, this review of metformin use. To begin, a historical overview is provided series demonstrates how metformin shows promise in many conditions, but how long can this drug remain at by Clifford Bailey (DOI

Journal

Diabetologia – Springer Journals

Published: Aug 3, 2017

There are no references for this article.